Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03151226 · ClinicalTrials.gov registry record · NA
OSA Screen Negative With Spinal Duramorph
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03151226 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 3 participants.
The verdict
NCT03151226, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Non emergent scheduled cesarean sections will be consented to participate in this study of patients who have screened negative for obstructive sleep apnea and who are also BMI\>/= 35 to have capnography monitoring postoperatively. The capnography and pulse oximetry will be initiated in the post anesthesia care unit and be worn for 12-24 hours after delivery. Data will be retrieved after that time period in a deidentified fashion. Medication usage will be reviewed as well as the standard of care information from the duramorph monitoring will be retrieved.
Interventions
- DEVICE Capnography monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-08-03 |
| Est. Completion | 2015-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03151226
The ClinicalTrials.gov registry entry for NCT03151226 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Capnography monitoring is the first listed.
NCT03151226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03151226 about?
NCT03151226 is a clinical study titled "OSA Screen Negative With Spinal Duramorph". Non emergent scheduled cesarean sections will be consented to participate in this study of patients who have screened negative for obstructive sleep apnea and who are also BMI\>/= 35 to have capnography monitoring postoperatively. The capnography and pulse oximetry will be initiated in the post anes...
What is the current status of trial NCT03151226?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2015-08-03. Estimated completion is 2015-10-01.
What interventions are being tested in trial NCT03151226?
The interventions under investigation include: Capnography monitoring (DEVICE).
Who is sponsoring clinical trial NCT03151226?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.